Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer
(Q47976225)
scientific article published on June 1, 1998
scientific article published on June 1, 1998
Language:
Current Data About
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer
other details
| description | scientific article published on June 1, 1998 |
External Links
| (P356) |
10.1200/JCO.1998.16.6.2150
|
| (P698) |
9626215
|